托珠单抗治疗强直性脊柱炎的反应不一。 - Suppr

Suppr

超能文献

Mixed response to tocilizumab for ankylosing spondylitis.

作者信息

Henes Joerg C, Horger Marius, Guenaydin Ilhan, Kanz Lothar, Koetter Ina

出版信息

Ann Rheum Dis. 2010 Dec;69(12):2217-8. doi: 10.1136/ard.2009.126706. Epub 2010 Jun 4.

DOI:10.1136/ard.2009.126706

PMID:20525837

Abstract

摘要

相似文献

Mixed response to tocilizumab for ankylosing spondylitis.托珠单抗治疗强直性脊柱炎的反应不一。

Ann Rheum Dis. 2010 Dec;69(12):2217-8. doi: 10.1136/ard.2009.126706. Epub 2010 Jun 4.

Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists.托珠单抗用于一名对肿瘤坏死因子拮抗剂难治的强直性脊柱炎和克罗恩病患者。

Joint Bone Spine. 2010 Dec;77(6):625-6. doi: 10.1016/j.jbspin.2010.08.004. Epub 2010 Sep 20.

Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.阿达木单抗可减轻活动性强直性脊柱炎的脊柱症状：一项为期52周的开放标签试验的临床和磁共振成像结果

Arthritis Rheum. 2006 Feb;54(2):678-81. doi: 10.1002/art.21563.

Effects of low-dose infliximab on spinal inflammation on magnetic resonance imaging in ankylosing spondylitis.低剂量英夫利昔单抗对强直性脊柱炎患者脊柱炎症的磁共振成像影响

J Rheumatol. 2010 Aug 1;37(8):1553-5. doi: 10.3899/jrheum.100422.

Intraarticular injection of infliximab.英夫利昔单抗关节腔内注射。

J Rheumatol. 2006 Sep;33(9):1912-3; author reply 1913.

Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab.英夫利昔单抗治疗强直性脊柱炎患者1年前后全身磁共振成像对广泛炎症性病变的评估

J Rheumatol. 2007 Dec;34(12):2497-8.

The HLA-B*2709 subtype in a woman with early ankylosing spondylitis.

Arthritis Rheum. 2007 Aug;56(8):2805-7. doi: 10.1002/art.22821.

When less is more.少即是多。

J Rheumatol. 2010 Jun;37(6):1089-90. doi: 10.3899/jrheum.100333.

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.阿达木单抗、依那西普和英夫利昔单抗治疗强直性脊柱炎：系统评价与经济学评估

Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. doi: 10.3310/hta11280.

Infliximab: in ankylosing spondylitis.英夫利昔单抗：用于强直性脊柱炎。

Drugs. 2005;65(9):1283-91; discussion 1292-4. doi: 10.2165/00003495-200565090-00006.

引用本文的文献

All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study.全反式维甲酸增强骨髓间充质干细胞对强直性脊柱炎的治疗效果：一项体外研究

Stem Cells Int. 2015;2015:484528. doi: 10.1155/2015/484528. Epub 2015 Jun 1.

Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN).托珠单抗治疗强直性脊柱炎：一项II期随机双盲安慰剂对照研究（ALIGN）的结果

Ann Rheum Dis. 2015 Jun;74(6):1051-7. doi: 10.1136/annrheumdis-2013-204963. Epub 2014 Feb 18.

[Interleukin-6 inhibition as a potential therapeutic target in rheumatic diseases].[白细胞介素-6抑制作为风湿性疾病潜在治疗靶点]

Z Rheumatol. 2014 Apr;73(3):269-76. doi: 10.1007/s00393-013-1268-9.

Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials.评估托珠单抗治疗强直性脊柱炎的短期症状疗效：随机、安慰剂对照试验的结果。

Ann Rheum Dis. 2014 Jan;73(1):95-100. doi: 10.1136/annrheumdis-2013-203559. Epub 2013 Jun 13.

Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.靶向白细胞介素 6：治疗自身免疫和炎症性疾病的新途径。

Int J Biol Sci. 2012;8(9):1227-36. doi: 10.7150/ijbs.4666. Epub 2012 Oct 24.

Pathological role of interleukin-6 in psoriatic arthritis.白细胞介素-6在银屑病关节炎中的病理作用。

Arthritis. 2012;2012:713618. doi: 10.1155/2012/713618. Epub 2012 Oct 11.

A sub-pathway based method to identify candidate agents for Ankylosing Spondylitis.基于子路径的方法识别强直性脊柱炎候选药物。

Molecules. 2012 Oct 22;17(10):12460-8. doi: 10.3390/molecules171012460.

Biologic therapies for spondyloarthritis: what is new?生物制剂治疗脊柱关节炎：有哪些新进展？

Curr Rheumatol Rep. 2012 Oct;14(5):422-7. doi: 10.1007/s11926-012-0282-2.

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study.IL-6 是否为治疗抗 TNF 治疗抵抗的脊柱关节炎患者的合适靶点？一项多中心回顾性观察研究。

Arthritis Res Ther. 2012 Mar 9;14(2):R53. doi: 10.1186/ar3766.

Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.托珠单抗治疗类风湿关节炎及其他全身性自身免疫性疾病：当前观点与未来方向

Int J Rheumatol. 2012;2012:946048. doi: 10.1155/2012/946048. Epub 2012 Jan 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验